Identification of a specific DNA region required for enhanced transcription of HER2/neu in the MDA-MB453 breast cancer cell line

被引:12
作者
Miller, SJ
Xing, XM
Xi, L
Hung, MC
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,BREAST CANC BASIC RES PROGRAM,HOUSTON,TX 77030
关键词
D O I
10.1089/dna.1996.15.749
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression and/or amplification of the HER2/neu gene has been shown in roughly 30% of breast cancer patients, Increased levels of HER2/neu mRNA in some breast cancer cell lines is partially caused by increased gene transcription, In MDA-MB453 human breast cancer cells, an activated trans-acting factor is involved in the increased transcription of HER2/neu by mediating its effects through a specific DNA region in the HER2/neu promoter, A methylation interference experiment showed a novel sequence for protein-DNA interactions, Three polypeptides of approximately 110, 70, and 35 kD interact with this DNA element, This region of the human HER2/neu promoter is highly conserved in the rat and mouse promoters and was shown to be capable of mediating transcriptional trans-activation in HER2/neu-overexpressing MDA-MB453 cells while having little effect in a control cell line that expresses basal levels of HER2/neu, Knowledge on interactions between this DNA element and nuclear protein factors may help us better understand the molecular mechanisms regulating HER2/neu overexpression in breast cancer cells.
引用
收藏
页码:749 / 757
页数:9
相关论文
共 39 条
[1]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[2]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[3]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[4]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[5]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[6]  
BERGER MS, 1988, CANCER RES, V48, P1238
[7]   THE DEVELOPMENTALLY-REGULATED TRANSCRIPTION FACTOR AP-2 IS INVOLVED IN C-ERBB-2 OVEREXPRESSION IN HUMAN MAMMARY-CARCINOMA [J].
BOSHER, JM ;
WILLIAMS, T ;
HURST, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :744-747
[8]   CORRELATION OF THE STRUCTURE OF THE TRANSMEMBRANE DOMAIN OF THE NEU ONCOGENE-ENCODED P185 PROTEIN WITH ITS FUNCTION [J].
BRANDTRAUF, PW ;
RACKOVSKY, S ;
PINCUS, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8660-8664
[9]   TYROSINE KINASE RECEPTOR WITH EXTENSIVE HOMOLOGY TO EGF RECEPTOR SHARES CHROMOSOMAL LOCATION WITH NEU ONCOGENE [J].
COUSSENS, L ;
YANGFENG, TL ;
LIAO, YC ;
CHEN, E ;
GRAY, A ;
MCGRATH, J ;
SEEBURG, PH ;
LIBERMANN, TA ;
SCHLESSINGER, J ;
FRANCKE, U ;
LEVINSON, A ;
ULLRICH, A .
SCIENCE, 1985, 230 (4730) :1132-1139
[10]   ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
KRAUS, MH ;
SEGATTO, O ;
KING, CR ;
AARONSON, SA .
SCIENCE, 1987, 237 (4811) :178-182